Ewa, LLC Vertex Pharmaceuticals Inc Transaction History

Ewa, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 18, 2025	BUY	$421.16 - $509.5 $40,852 - $49,421	97 Added 16.61%	681 $303 Million
Q1 2025 Apr 22, 2025	SELL	$402.49 - $513.76 $3,622 - $4,623	-9 Reduced 1.52%	584 $283 Million
Q4 2024 Feb 14, 2025	BUY	$396.64 - $516.74 $12,692 - $16,535	32 Added 5.7%	593 $239 Million
Q3 2024 Nov 15, 2024	BUY	$460.0 - $505.78 $28,520 - $31,358	62 Added 12.42%	561 $272 Million
Q2 2024 Jul 24, 2024	BUY	$392.81 - $485.53 $7,856 - $9,710	20 Added 4.18%	499 $245 Million

Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $195,283 - $213,672	479 New	479 $203 Million

1,787

231M

1.83M

1.21M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $111B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Ewa, LLC, based on Form 13F filings with the SEC.

Stay updated on Ewa, LLC with notifications on news.